Mont-Saint-Guibert, Belgium - Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to present at four investor conferences in February and March 2019.


Conference details:

8th Annual SVB Leerink Global Healthcare Conference

Date: Thursday, February 28, 2019

Presentation time: 1:30 p.m. ET

Location: New York, NY

A live webcast of the presentation can be accessed here.

 

Cowen 39th Annual Health Care Conference

Date: Monday, March 11, 2019

Presentation Time: 3:30 p.m. ET

Location: Boston, MA

A live webcast of the presentation can be accessed here

 

BioCapital Europe 2019*

Date: Thursday, March 14, 2019

Presentation Time: 3:20 p.m. CET

Location: Amsterdam

 

William Blair 9th Annual Cancer Immunotherapy Conference*

Date: Wednesday, March 20, 2019

Presentation Time: 10:30 a.m. ET

Location: New York, NY

An archived recording of the webcasts noted above will also be available under Events & Webcasts in the Investors section of the Company’s website.


[*] This event will not be webcast.

Download press release(s)

Press release

93.20 Ko

Communiqué de presse

71.24 Ko

Persbericht

94.54 Ko

Celyad Appoints Anne Moore as Vice President Corporate Strategy

Next News

Celyad Appoints Anne Moore as Vice President Corporate Strategy